"Here, we have developed a robust computational framework to determine the prognostic strengths of a variety of molecular features relative to conventionally utilized clinical factors such as tumor stage, age, and histopathology across a vast compendia of cancer cohorts from TCGA."
https://www.cell.com/cell-genomics/fulltext/S2666-979X(23)00018-6